Reuters logo
BRIEF-Pfizer says European Commission has approved Xalkori the treatment of adults with lung cancer
2016年8月31日 / 中午11点37分 / 1 年前

BRIEF-Pfizer says European Commission has approved Xalkori the treatment of adults with lung cancer

Aug 31 (Reuters) - Pfizer Inc

* European Commission has approved XALKORI for treatment of adults with ros1-positive advanced non-small cell lung cancer

* In European Union, XALKORI is also indicated for treatment of adults with anaplastic lymphoma kinase-positive advanced NSCLC Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below